Ainos, Inc. reported financial results for the third quarter ended September 30, 2026, highlighting a significant increase in revenue driven by its semiconductor-focused AI Nose program and VELDONA licensing. The company announced that total revenue for the quarter reached $642,889, representing a year-over-year increase of 29,567%. This growth was attributed to the recognition of a one-time $600,000 initial VELDONA license fee and revenue from the AI Nose semiconductor program.
Financial performance metrics showed improvement compared to the prior year. GAAP net loss narrowed by 36% year over year to $1,886,074. The company also reported a GAAP gross margin of 83.4% for the quarter, an expansion from 78.0% in the third quarter of 2025. Additionally, GAAP operating expenses declined by 20.3% year over year.
On the operational front, Ainos delivered 1,400 AI Nose systems to a backend semiconductor customer under a $2.1 million, three-year subscription agreement. The company stated that it expects this agreement to contribute approximately $175,000 in recurring revenue per quarter beginning in the fourth quarter of 2026. Following the quarter-end, the company secured a follow-on order for an additional 5,000 AI Nose systems from the same customer, valued at $9 million. This agreement includes an initial payment of $4.5 million due within 60 days of signing.
Ainos also highlighted progress in its data and technology platforms. The company’s real-world chemical dataset surpassed 3 billion records in October, up from over 1 billion in September. The company introduced a second-generation AI Nose system and launched the Atmosphere Engine, a modular platform designed to generate nitrogen and oxygen from ambient air. Furthermore, Ainos completed the technology transfer for VELDONA and established a potential $10 million licensing framework for two initial indications.